We are all-in on the drive to zero

Mission

Advancing SSI Control & Prevention

Surgeons and their teams are leaders, problem solvers, and healers. They, along with infection control experts, are continuously and tirelessly working to improve their SSI prevention and control protocols. We share their belief that surgical site infection should never be considered an inevitable outcome of high risk surgery. Our role is to support the hospital drive to zero by developing advanced technology that enhances hospital SSI infection control programs and bundles.

We believe that with technological innovation, greater awareness, and ongoing collaboration around best practices, we can help surgeons and hospitals significantly improve post-operative outcomes and patients' lives.

 

The UnMet need

Critical Gaps in SSI Care

Surgical site infections (SSI) are a major source of illness following surgery, particularly acute in the 1MM+ annual high-risk abdominal surgeries where 15%+ of patients develop an infection.1,2,3 Patients suffer, healthcare costs rise, and hospitals and surgeons are penalized. Wound contamination is the root cause of SSI, yet after nearly a decade of national SSI focus, surgical teams still struggle to gain control over this pervasive, invisible threat. Current surgical technologies have not evolved to adequately eliminate contamination, creating critical gaps that expose patients to infection. Hospital leaders are searching for the next generation of proven approaches to close these gaps, improve their infection control programs, and define a new standard of care.

Our Story

A Multi-Disciplinary Mind Meld

Our company was conceived at the Stanford Byers Center for Biodesign and accelerated at Stanford StartX Med and the Fogarty Institute for Innovation. Through extensive research and work with hospitals and patients, we realized that while new surgical techniques had transformed many areas of surgical practice, there had been little innovation in tools for peri-operative infection control. 

We knew it would take the talents of a multi-disciplinary team to tackle SSI. Our team and board of advisors includes experts in surgery, infection control, and medical technology development and commercialization. Their deep understanding of the SSI challenge plays a key role in the design and development of advanced technology that has immediate utility and longer-term benefits for hospital infection control programs.

Zeroing in on Abdominal Surgery

Our first area of focus is abdominal surgery, with an emphasis on colorectal surgery where the risk, frequency and severity of surgical site infection is high and the need is acute. Nearly 50 percent of abdominal incisions are contaminated during surgery.4 Our team collaborated closely with leading hospitals in abdominal surgery to create a technology platform and product that could be used in the full range of open and minimally invasive approaches utilized in their procedures.

Designed for Ease of Use & Control

Every aspect of our design and development is focused on putting more control into the expert hands of surgical and infection control and prevention teams. Surgeons and infection control experts in hospitals across the country provided critical feedback during our development process. These close collaborations are an integral part of how we work. The result is a first-in-class, advanced system that fits naturally and seamlessly into surgical workflow.

Leadership

Jonathan Coe

Jonathan Coe

Co-Founder, President & CEO

Jeremy Koehler

Jeremy Koehler

Co-Founder, Director of R&D

Lisa Claude

Lisa Claude

Senior Director of Clinical & Regulatory Affairs

Steve Lopez

Steve Lopez

Senior Director of Operations

Board of Directors

Brant Heise

Board Director
Managing Director, Summation Health Ventures

Eugene Chen

Executive Chair,
Managing Director, CWC HealthTech Advisors

Greg Bakan

Board Director
Chief Operating Officer, Fogarty Institute for Innovation

Advisory Board

Donald Fry MD

Executive Vice President for Clinical Outcomes, MPA Healthcare Solutions; Adjunct Professor of surgery at Northwestern University, Chicago, IL; Professor Emeritus, Department of Surgery at University of New Mexico School of Medicine, Albuquerque, NM. Previous leadership positions: Chair of the Department of Surgery at University of New Mexico; Chief of Surgery at University of New Mexico Hospital; President of the Surgical Infection Society of North America; President, Association of Virginia Surgeons

Insoo Suh MD

Co-Founder Prescient Surgical; Assistant Professor of Surgery, Division of General Surgery, Endocrine Surgery Section; Director of Research, Endocrine Surgical Oncology Lab, University of California, San Francisco

Mark Welton MD, MHCM, FACS, FASCRS

Co-Founder Prescient Surgical; Chief Medical Officer, Fairview Health Services, Minneapolis, MN; Professor of Surgery, University of Minnesota. Previous leadership positions: Harry A. Oberhelman Jr. Professor and Chief of Colon and Rectal Surgery at Stanford University School of Medicine, Palo Alto, CA; Chief of Staff, Stanford Hospital and Clinics; Medical Director of the Stanford Clinical Cancer Center.

Michael Goldfarb MD, FACS

Professor of Surgery, Drexel University College of Medicine, Philadelphia, PA. Previous leadership positions: Chair and Program Director, Department of Surgery, Monmouth Medical Center; Medical Director of Cramner Ambulatory Surgery Center, Monmouth Medical Center; Surgical coordinator, Jacqueline M. Wilentz Comprehensive Breast Center, Monmouth Medical Center, Monmouth, NJ; NJ Chapter President, American College of Surgeons; President, Society of Surgeons of New Jersey.

Motaz Qadan MD, PhD

Surgical Oncologist, Massachusetts General Hospital; Assistant Professor of Surgery, Harvard Medical School, Boston, MA. Previous leadership positions: Fellowship educational coordinator at Memorial Sloan-Kettering Cancer Center; Administrative Chief Resident, Stanford University School of Medicine, Palo Alto, CA.

Sue Barnes RN, CIC, FAPIC

Independent Clinical Consultant, Board certified in Infection Control and Prevention, Fellow of APIC (FAPIC). Previous leadership positions: National APIC Board of Directors; San Francisco APIC Chapter Board of Directors; Corporate Director Infection Prevention and Control Services, Kaiser Permanente.

Thomas Krummel MD, FACS/FAAP

Chair of Fogarty Institute for Innovation, Co-Director of Stanford Byers Center for Biodesign Program, Emile Holman professor at Stanford University School of Medicine, Palo Alto, CA. Previous leadership positions: Susan B. Ford Surgeon-in-Chief, Lucile Packard Children’s Hospital; Program Director of the General Surgery Residency Training Program, Stanford University, and former chair of the department of surgery, Stanford University School of Medicine.

Yuman Fong MD

Professor and chair of department of surgery at City of Hope, Sangiacomo Family chair of surgical oncology at City of Hope, Duarte, CA. Previous leadership positions: Murray F. Brennan chair of surgery, Memorial Sloan-Kettering Cancer Center, New York, NY; Vice Chair of Technology Development, Memorial Sloan-Kettering Cancer Center; Professor of Surgery, Weill Cornell Medical College, New York, NY.

Collaborations

Baylor University Medical Center

Dallas, TX

Intermountain McKay-Dee Hospital

Ogden, UT

Stony Brook Medicine

Stony Brook, NY

Baylor Scott & White

Temple, Texas

Washington University School of Medicine

St. Louis, Missouri

Lahey Hospital and Medical Center

Burlington, Massachusetts

Ochsner Clinic

New Orleans, Louisiana

Contact Us

Ready to get started?

Get in touch

References

1 Tanner J, Khan D, Aplin C, Ball J, Thomas M, Bankart J. Post-discharge surveillance to identify colorectal surgical site infection rates and related costs. J Hosp Infect. 2009;72(3):243-250.

2 Watanabe A, Kohnoe S, Shimabukuro R, et al. Risk factors associated with surgical site infection in upper and lower gastrointestinal surgery. Surg Today. 2008;38(5):404-412.

3 Wick EC, Vogel JD, Church JM, Remzi F, Fazio VW. Surgical site infections in a "high outlier" institution: are colorectal surgeons to blame? Dis Colon Rectum. 2009;52(3):374-379.

4 Fa-Si-Oen PR, Kroeze F, Verhoef LH, Verwaest C, Roumen RM. Bacteriology of abdominal wounds in elective open colon surgery: a prospective study of 100 surgical wounds. Clin Microbiol Infect. 2005;11(2):155-157.